SENTIRIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Dec 2023)
What this means for you
This application is over — abandoned 25 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88906847
- Mark type
- Design + words
- Filed
- 08 May 2020
- Published for opposition
- 29 Sept 2020
- Abandoned
- 25 Dec 2023
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 042 — Scientific and technological services: Scientific research and development services, namely, high throughput screening services to support therapeutic and diagnostic drug development; scientific research and development services, namely, the development of assays and cell models for use in high throughput screening for clinical and laboratory use; consulting services for scientific research purposes in the area of high throughput screening and assay design
Owner
- DiscoveryBioMed, Inc., Birmingham, AL, US
- DiscoveryBioMed, Inc., Birmingham, AL, US
Prosecution history
- 26 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 13 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2023 — SOU EXTENSION 5 GRANTED
- 09 May 2023 — SOU EXTENSION 5 FILED
- 12 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 May 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Nov 2022 — SOU EXTENSION 4 GRANTED
- 23 Nov 2022 — SOU EXTENSION 4 FILED
- 23 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 26 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2022 — SOU EXTENSION 3 GRANTED
- 24 May 2022 — SOU EXTENSION 3 FILED
- 24 May 2022 — SOU TEAS EXTENSION RECEIVED